Search Results - "Chulanov, V. P."

Serological diagnosis and prevalence of HIV-1 infection in Russian metropolitan areas by Kireev, D E, Chulanov, V P, Shipulin, G A, Semenov, A V, Tivanova, E V, Kolyasnikova, N M, Zueva, E B, Pokrovskiy, V V, Galli, C

“…HIV infection is a major health problem in Russia. We aimed to assess HIV prevalence in different population groups and to compare the characteristics of 4th…”
Get full text

Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C by Klimova, E A, Burnevich, E Z, Chulanov, V P, Gusev, D A, Znoyko, O O, Batskikh, S N, Kizlo, S N, Mamonova, N A, Tarkhova, E P, Krasavina, E N, Samsonov, M Yu, Yushchuk, N D

“…Aim. Evaluate efficacy and safety of a combination of direct - acting antivirals narlaprevir/ritonavir with daclatasvir in patients with viral hepatitis C…”
Get full text

Hepatitis C can be cured: will hepatitis B become next? by V P Chulanov, A P Zueva, D S Kostyushev, S A Brezgin, E V Volchkova, V V Maleyev

“…Chronic hepatitis B (CHB) and C (CHC) are one of the leading causes of cirrhosis and liver cancer with over a million of people dying annually from their…”
Get full text

INCREASED FORMATION OF PHOSPHORYLATED H2AX FOCI IN NUCLEI OF CELLS INFECTED BY HEPATITIS B AND B+D VIRUSES by Kostyushev, D. S., Brezgin, S. A., Kostyusheva, A. P., Lipatnikov, A. D., Simirskii, V. N., Mamonova, N. A., Volchkova, E. V., Maleyev, V. V., Chulanov, V. P.

“…Liver cirrhosis and hepatocellular carcinoma are the most common outcomes of chronic hepatitis B. Hepatitis B virus (HBV) induces transformation and cell death…”
Get full text

Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B by D S Kostyushev, A P Zueva, S A Brezgin, A D Lipatnikov, V N Simirskii, D Glebe, E V Volchkova, G A Shipulin, V P Chulanov

“…Aim. To define the role of DNA-methyltransferases of type 1 and type 3A in hepatitis B viral cycle. Materials and methods. Human hepatoma cells HepG2 with…”
Get full text

Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C by Batskikh, S N, Karandashova, I V, Neverov, A D, Chulanov, V P

“…To clarify the role of virus resistance in the efficiency of antiviral therapy with protease inhibitors (PIs) chronic hepatitis C (CHC) patients, with moderate…”
Get full text

Chronic hepatitis C in Russia: current challenges and prospects by Chulanov, V P, Pimenov, N N, Mamonova, N A, Sagalova, O I, Shestakova, I V, Pokrovsky, V I

“…This paper evaluates the impact of different medical care strategies for chronic hepatitis C patients in relation to its prevalence, frequency of adverse…”
Get full text

The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia by Pimenov, N N, Vdovin, A V, Komarova, S V, Mamonova, N A, Chulanov, V P, Pokrovskiĭ, V I

“…The article provides the current epidemiological characteristics of viral hepatitis B and C and the existing problems of registering parenteral viral…”
Get full text

Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy by Zhuravleva, M. V., Chulanov, V. P., Gagarina, Yu. V., Shabalina, E. A.

“…Objective : to evaluate the pharmacoeconomic feasibility of using monoclonal antibodies or their combinations vs standard therapy in patients with mild and…”
Get full text

Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo by Kostyusheva, A. P., Brezgin, S. A., Ponomareva, N. I., Goptar, I. A., Nikiforova, A. V., Gegechkori, V. I., Poluektova, V. B., Turkadze, K. A., Sudina, A. E., Chulanov, V. P., Kostyushev, D. S.

“…Chronic hepatitis B (CHB) is caused by hepatitis B virus (HBV) infection. This disease is a key issue for global health. Modern methods of therapy do not…”
Get full text

Stochastic Packaging of Cas Proteins into Exosomes by Ponomareva, N I, Brezgin, S A, Kostyusheva, A P, Slatinskaya, O V, Bayurova, E O, Gordeychuk, I V, Maksimov, G V, Sokolova, D V, Babaeva, G, Khan, I I, Pokrovsky, V S, Lukashev, A S, Chulanov, V P, Kostyushev, D S

“…CRISPR/Cas systems are perspective molecular tools for targeted manipulation with genetic materials, such as gene editing, regulation of gene transcription,…”
Get more information

Epidemiological Features of the COVID-19 and Characteristics of Patients during the Spread of the Omicron SARS-COV-2 in Russia by Fomicheva, A. A., Pimenov, N. N., Komarova, S. V., Urtikov, A. V., Tsapkova, N. N., Sakhautdinov, A. R., Strelkova, D. A., Nekludova, G. V., Rachina, S. A., Avdeev, S. N., Chulanov, V. P.

“…Aim. To analyze dynamic of incidence and mortality of COVID-19 and clinical and epidemiological characteristics of adult patients with a new coronavirus…”
Get full text

Stochastic Packaging of Cas Proteins into Exosomes by Ponomareva, N. I., Brezgin, S. A., Kostyusheva, A. P., Slatinskaya, O. V., Bayurova, E. O., Gordeychuk, I. V., Maksimov, G. V., Sokolova, D. V., Babaeva, G., Khan, I. I., Pokrovsky, V. S., Lukashev, A. S., Chulanov, V. P., Kostyushev, D. S.

“…—CRISPR/Cas systems are perspective molecular tools for targeted manipulation with genetic materials, such as gene editing, regulation of gene transcription,…”
Get full text

Features of the covid-19 epidemic and characteristics of patients during the spread of the delta SARS-COV-2 in Russia by Fomicheva, A. A., Pimenov, N. N., Komarova, S. V., Urtikov, A. V., Tsapkova, N. N., Proshkina, A. A., De Silva, S. H.R., Vlasenko, A. E., Strelkova, D. A., Nekludova, G. V., Rachina, S. A., Avdeev, S. N., Chulanov, V. P.

“…Aim: To study the manifestations of the COVID-19 epidemic and the clinical and epidemiological characteristics of adult patients with a new coronavirus…”
Get full text

HBx Protein Potentiates Hepatitis B Virus Reactivation by Brezgin, S. A., Kostyusheva, A. P., Ponomareva, N. I., Gegechkori, V. I., Kirdyashkina, N. P., Ayvasyan, S. R., Dmitrieva, L. N., Kokoreva, L. N., Chulanov, V. P., Kostyushev, D. S.

“…Hepatitis B virus (HBV) can cause chronic hepatitis B, one of the most prevalent infectious diseases in the world. Global estimates suggest that over 2 billion…”
Get full text

Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain by Znoiko, O O, Dudina, K R, Safiullina, N Kh, Karandashova, I V, Chulanov, V P

“…The paper gives concise data on the efficacy of entecavir in the treatment of chronic hepatitis B caused by its resistant virus strain and describes a relevant…”
Get full text

Small Molecular Inhibitors of DNA Double Strand Break Repair Pathways Increase the ANTI-HBV Activity of CRISPR/Cas9 by Kostyusheva, A. P., Kostyushev, D. S., Brezgin, S. A., Zarifyan, D. N., Volchkova, E. V., Chulanov, V. P.

“…The CRISPR/Cas9 nuclease system can effectively suppress the replication of the hepatitis B virus (HBV), while covalently closed circular DNA (cccDNA), a…”
Get full text

The resolution of the Expert Council on the Diagnosis, Treatment, and Prevention of Symptoms of Depression in Outpatients with New Coronavirus Infection by Drapkina, O. M., Grigorova, O. V., Dzhioeva, O. N., Kostyuk, G. P., Neznanov, N. G., Samushiya, M. A., Chulanov, V. P.

Get full text

Use of non-steroidal anti-inflammatory drugs during the COVID-19 pandemic. Resolution of the Expert Council of the Russian Society for the Prevention of Noncommunicable Diseases by Drapkina, O. M., Avdeev, S. N., Gorelov, A. V., Chulanov, V. P., Alekseeva, L. I., Danilov, A. B., Tabeeva, G. R., Pchelintsev, M. V.

“…The spread and consequences of the coronavirus disease 2019 (COVID-19) pandemic are currently one of the most pressing public health challenges in the world…”
Get full text

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C by Ivashkin, V. T., Chulanov, V. P., Mamonova, N. A., Maevskaya, M. V., Zharkova, M. S., Tikhonov, I. N., Bogomolov, P. O., Volchkova, E. V., Dmitriev, A. S., Znojko, O. O., Klimova, E. A., Kozlov, K. V., Kravchenko, I. E., Malinnikova, E. Yu, Maslennikov, R. V., Mikhailov, M. I., Novak, K. E., Nikitin, I. G., Syutkin, V. E., Esaulenko, E. V., Sheptulin, A. A., Shirokova, E. N., Yushchuk, N. D.

“…Аim: diagnosis and treatment algorithms in the clinical recommendations intended for general practitioners, gastroenterologists, infectious disease…”
Get full text